{
    "organizations": [],
    "uuid": "e0fe85e3d123eaa68124ed5a60a3c3393fdf19b3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fda-expands-approval-of-blincyto/brief-fda-expands-approval-of-blincyto-idUSFWN1RB0WK",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Expands Approval Of Blincyto",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29, 2018 / 5:21 PM / Updated 10 minutes ago BRIEF-FDA Expands Approval Of Blincyto Reuters Staff 1 Min Read \nMarch 29 (Reuters) - The U.S. Food and Drug Administration: \n* FDA EXPANDS APPROVAL OF BLINCYTO FOR TREATMENT OF A TYPE OF LEUKEMIA IN PATIENTS WHO HAVE A CERTAIN RISK FACTOR FOR RELAPSE * SAYS GRANTED APPROVAL OF BLINCYTO TO AMGEN \n* SAYS BLINCYTO CARRIES A BOXED WARNING Further company coverage:",
    "published": "2018-03-29T20:19:00.000+03:00",
    "crawled": "2018-03-29T20:32:53.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "expands",
        "approval",
        "blincyto",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "expands",
        "approval",
        "blincyto",
        "treatment",
        "type",
        "leukemia",
        "patient",
        "certain",
        "risk",
        "factor",
        "relapse",
        "say",
        "granted",
        "approval",
        "blincyto",
        "amgen",
        "say",
        "blincyto",
        "carry",
        "boxed",
        "warning",
        "company",
        "coverage"
    ]
}